BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

Bionomics novel vascular disruption treatment recognized among...

  1. shareguy
    101 Posts.
    clock Created with Sketch.
    08/06/08
    15:25
    Post #: 3831160
    Bionomics novel vascular disruption treatment recognized among leading drugs entering phase 1 trials. Broadening chart pattern indicative of a well-supported and managed biotech outfit. Surely among better biotechs..! Such long accumulative chart patterns can rally explosively once the buyers strongly outnumber sellers. Note the tightening range of price volatility...indicative of large holder accummulations....!
    BNO Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Strategic investment secured for QLD and NSW bauxite projects
right-arrow Created with Sketch.
NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.